摘要
目的探讨体外受精-胚胎移植(IVF-ET)周期中黄体期血清性激素水平的变化及与妊娠率的关系。方法随机选取62个采用卵泡刺激素/绝经期促性腺激素/绒毛膜促性腺激素(FSH/hMG/hCG)促超排卵的IVF-ET周期(62例患者),采用放射免疫测定技术,测定其自然周期与促超排卵周期中黄体期血清雌二醇(E2)、孕酮(P)、催乳素(PRL)水平,观察其妊娠情况。结果促超排卵周期中黄体期血清性激素水平明显高于自然周期(P<0.05)。补充黄体酮者的P、P/E2值,明显高于未补充黄体酮者(P<0.05)。临床妊娠者的E2水平明显低于未妊娠者,而P/E2、PRL值明显高于未妊娠者(P<0.05),并且当P/E2值为300~400、PRL值为60~100μg/L时妊娠率最高。结论IVF-ET周期中黄体期血清性激素水平对妊娠有影响,其中E2、P协同发挥作用,PRL在一定范围内有利于胚胎着床。在IVF-ET中应适当补充黄体酮,调节性激素至最适水平。
Objective To study the influence of maternal endocrine factors on clinical pregnancy outcome in an in Vitro Fertilization Embryo Transfer (IVFET) program. Methods 62 IVFET treatment cylces were studied. Luteal phase serum sex hormone levels [estrogen (E2), progesterone (P), prolactin (PRL)] in natural and superovulation cycles were measured by radioimmunoassay and the clinical pregnancy outcome was observed. Results Serum luteal phase sex hormone levels were higher than in natural cycles (P<0.05). P level and P/E2 ratio in progesterone supplementation group were higher than the group without progesterone supplementation (P<0.05). In pregnancy group serum E2 (4 885.5±1 269.0 pmol/L) was lower, PRL (66.4±26.8 μg/L), P/E2 (373.0±152.5) were higher than in nonpregnancy group (E2 6 091.2±1 522.1 pmol/L, PRL 49.1±24.1 μg/L, P/E2 227.4±116.7) (P<0.05). When P/E2 ratio was between 300~400 and PRL level was between 60~100 μg/L, the clinical pregnancy rate increased markedly (P<0.05). Conclusion Luteal phase serum sex hormone level may influence embryo implantation in IVFET. In order to improve the clinical pregnancy rate, it is very necessary to supplement progesterone for the IVFET patients according to the different sex hormone levels.
出处
《中华妇产科杂志》
CAS
CSCD
北大核心
1998年第8期484-486,共3页
Chinese Journal of Obstetrics and Gynecology
关键词
胚胎
着床
黄体期
性激素类
体外受精
Fertilization in vitro Embryo transfer Luteal phase Sex hormones Pregnancy outcome